Home
Company Info
Company Profile and Strategy
Management Team
Corporate Governance
Investor Relations
Investor Home
Press Release Archive
Company Facts Report
Broker Forecasts
Email Alerts
Trading Info
Financial Reports and Shareholder Meetings
Advisers & Registrars
Presentations
Financial Calendar
Shareholder FAQs
Contact Details
Partnering & Licensing
Contact Us
Glossary
Navigation menu
Gene Therapeutics
Bio Manufacturing
>
GMP3 Virtual Tour
Small Molecules in Vascular Biology
Ark Therapeutics, From science To patients
Change of Broker
16 January 2012
Early success of Ark's manufacturing partnership with PsiOxus
04 January 2012
Ark Therapeutics signs manufacturing agreement with University of Glasgow
03 November 2011
Ark Therapeutics and PsiOxus Therapeutics enter manufacturing partnership
12 September 2011
Read more news stories here
2nd Interim Management Statement published
09 November 2011
2011 Interim Report published
24 August 2011
Preliminary results for the year ended 31 December 2010
09 March 2011
2010 Preliminary Results Presentation
09 March 2011
Visit the Investor Relations section of the web site.
Edison Investment Research
01 September 2011
Matrix Corporate Capital LLP
24 August 2011
Edison Investment Research
05 July 2011
Matrix Corporate Capital LLP
11 April 2011
3.52 p
Change: 0.14p
Last Trade: 28/1/2012 10:07
View share price data
Use the search form below to search our site.
Search
Download the latest Annual Report & Accounts
[1MB]
Keep up-to-date with product developments, investor relations information and news with our email updates.
Register here to receive our email alerts.
©2012 Ark Therapeutics Group plc. All rights reserved | Site Design and Maintenance by
3wise Internet Solutions
To view PDF files on this site, you will need Adobe Acrobat Reader.
Download it for free here.
Stats Script
Stats Script